Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

6
results for

"Acute Kidney Injury"

Article category

Keywords

Publication year

"Acute Kidney Injury"

Reviews

Liver fibrosis, cirrhosis, and portal hypertension

Hepatorenal syndrome: Current concepts and future perspectives
Chan-Young Jung, Jai Won Chang
Clin Mol Hepatol 2023;29(4):891-908.
Published online April 13, 2023
DOI: https://doi.org/10.3350/cmh.2023.0024
Hepatorenal syndrome (HRS), a progressive but potentially reversible deterioration of kidney function, remains a major complication in patients with advanced cirrhosis, often leading to death before liver transplantation (LT). Recent updates in the pathophysiology, definition, and classification of HRS have led to a complete revision of the nomenclature and diagnostic criteria for HRS type 1, which was renamed HRS-acute kidney injury (AKI). HRS is characterized by severe impairment of kidney function due to increased splanchnic blood flow, activation of several vasoconstriction factors, severe vasoconstriction of the renal arteries in the absence of kidney histologic abnormalities, nitric oxide dysfunction, and systemic inflammation. Diagnosis of HRS remains a challenge because of the lack of specific diagnostic biomarkers that accurately distinguishes structural from functional AKI, and mainly involves the differential diagnosis from other forms of AKI, particularly acute tubular necrosis. The optimal treatment of HRS is LT. While awaiting LT, treatment options include vasoconstrictor drugs to counteract splanchnic arterial vasodilation and plasma volume expansion by intravenous albumin infusion. In patients with HRS unresponsive to pharmacological treatment and with conventional indications for kidney replacement therapy (KRT), such as volume overload, uremia, or electrolyte imbalances, KRT may be applied as a bridging therapy to transplantation. Other interventions, such as transjugular intrahepatic portosystemic shunt, and artificial liver support systems have a very limited role in improving outcomes in HRS. Although recently developed novel therapies have potential to improve outcomes of patients with HRS, further studies are warranted to validate the efficacy of these novel agents.

Citations

Citations to this article as recorded by  Crossref logo
  • Paracentesis exceeding three liters increases risks of acute kidney injury even in cirrhotic patients with albumin infused refractory ascites
    Pei-Shan Wu, Kuei-Chuan Lee, Chih-Yu Li, Yun-Cheng Hsieh, Teh-Ia Huo, Han-Chieh Lin, Ming-Chih Hou
    Journal of the Formosan Medical Association.2026; 125(3): 268.     CrossRef
  • Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases
    Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • Rising mortality due to coexisting liver cirrhosis and kidney failure in the United States (1999–2023): A nationwide retrospective analysis
    Muhammad Shaheer Bin Faheem, Syed Tawassul Hassan, Syeda Umbreen Munir, Muhammad Idrees Khan
    Medicine.2026; 105(9): e47662.     CrossRef
  • Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy
    Clelia Asero, Francesca Polito, Maria Stella Franzé, Antonio Battaglia, Claudia Ligresti, Teresa Maltese, Irene Cacciola, M’Hammed Aguennouz, Vincenzo Macaione
    Frontiers in Molecular Biosciences.2026;[Epub]     CrossRef
  • Trends and Demographics of Hepatorenal Syndrome-Related Mortality in the U.S., 1999–2024: A CDC WONDER Analysis
    Syed Faisal Ali, Julia Natche, Mahendrakumar Achlaram Chaudhari, Hassan Abbasi, Sammy Dawoud, Hany Dawoud, Amna Shoaib, Hersh Tilokani, Harleen Kaur Chela, Arsal Zafar
    Diseases.2026; 14(3): 106.     CrossRef
  • Association of visceral fat obesity with structural change in abdominal organs: fully automated three-dimensional volumetric computed tomography measurement using deep learning
    Haruka Kiyoyama, Masahiro Tanabe, Mayumi Higashi, Naohiko Kamamura, Yosuke Kawano, Kenichiro Ihara, Keiko Hideura, Katsuyoshi Ito
    Abdominal Radiology.2025; 50(9): 4395.     CrossRef
  • Understanding and Treating Hepatorenal Syndrome: Insights from Recent Research
    Yuli Song, Xiaochen Yang, Chengbo Yu
    Seminars in Liver Disease.2025; 45(03): 328.     CrossRef
  • Ascites complications risk factors of decompensated cirrhosis patients: logistic regression and prediction model
    Xiaolong Zheng, Wei Wei
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Emergency living donor liver transplantation
    Jongman Kim
    Annals of Liver Transplantation.2025; 5(1): 27.     CrossRef
  • Assessment of Albumin Therapy and Paracentesis Interval in Cirrhotic Patients With Recurrent Ascites: A Prospective Cohort Study
    Muhammad Abdullah Khan, Hafiz Muhammad Faizan Mughal, Shehwar Ahmed, M Khaliq, Abdul Ghafoor
    Cureus.2025;[Epub]     CrossRef
  • Acute Kidney Injury in Patients with Liver Cirrhosis: From Past to Present Definition and Diagnosis
    Andreea Lungu, Georgiana-Elena Sarbu, Alexandru Sebastian Cotlet, Ilie-Andreas Savin, Ioana-Roxana Damian, Simona Juncu, Cristina Muzica, Irina Girleanu, Ana-Maria Sîngeap, Carol Stanciu, Anca Trifan, Camelia Cojocariu
    Life.2025; 15(8): 1249.     CrossRef
  • Oral Branched-Chain Amino Acids as a Cost-Effective Option for Managing Hepatic Encephalopathy
    Hankil Lee, Sang Hoon Ahn, Beom Kyung Kim
    Yonsei Medical Journal.2025; 66(11): 713.     CrossRef
  • Life after hepatorenal syndrome: unraveling quality of life, psychological distress, and treatment preferences
    J. Müller-Kühnle, M. Schanz, J. Latus, D. Marschner, S. Schricker
    BMC Palliative Care.2025;[Epub]     CrossRef
  • The Kidney in the Shadow of Cirrhosis: A Critical Review of Renal Failure
    Livia-Mirela Popa, Paula Anderco, Oana Stoia, Cristian Ichim, Corina Porr
    Biomedicines.2025; 13(11): 2775.     CrossRef
  • Predicting risk factors for waiting mortality in adult emergent living donor liver transplantation based on Korean national data
    Sang Jin Kim, Jongman Kim, Kyunga Kim, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung
    Annals of Liver Transplantation.2025; 5(2): 107.     CrossRef
  • VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis
    Shohei Asada, Tadashi Namisaki, Kosuke Kaji, Hiroaki Takaya, Takahiro Kubo, Takemi Akahane, Hideto Kawaratani, Norihisa Nishimura, Soichi Takeda, Hiroyuki Masuda, Akihiko Shibamoto, Takashi Inoue, Satoshi Iwai, Fumimasa Tomooka, Yuki Tsuji, Yukihisa Fujin
    Digestive Diseases and Sciences.2024; 69(3): 851.     CrossRef
  • Gut Microbiota and Biomarkers of Endothelial Dysfunction in Cirrhosis
    Irina Efremova, Roman Maslennikov, Elena Poluektova, Oleg Medvedev, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Filipp Romanikhin, Vyacheslav Bakhitov, Salekh Aliev, Natalia Sedova, Tatiana Kuropatkina, Anastasia Ivanova, Maria Zharkova, Ekaterina
    International Journal of Molecular Sciences.2024; 25(4): 1988.     CrossRef
  • Infection-Related Readmissions Are Rising among Patients with Hepatorenal Syndrome: A Nationwide Analysis
    Umer Farooq, Zahid I. Tarar, Ammad J. Chaudhary, Abdallah E. Alayli, Faisal Kamal, Chengdu Niu, Kamran Qureshi
    Livers.2024; 4(2): 268.     CrossRef
  • Management of hepatorenal syndrome and treatment-related adverse events
    Lorenzo Peluso, Marzia Savi, Giacomo Coppalini, Deliana Veliaj, Nicola Villari, Giovanni Albano, Stephen Petrou, Maria C. Pace, Marco Fiore
    Current Medical Research and Opinion.2024; 40(7): 1155.     CrossRef
  • Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
    M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi, S.L. Chub, Yu.V. Nerushchenko
    GASTROENTEROLOGY.2024; 58(2): 151.     CrossRef
  • Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats
    João Bruno Beretta Duailibe, Cassiana Macagnan Viau, Jenifer Saffi, Sabrina Alves Fernandes, Marilene Porawski
    World Journal of Nephrology.2024;[Epub]     CrossRef
  • Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function
    Xingyue Huang, Jas Bindra, Ishveen Chopra, John Niewoehner, George J. Wan
    Advances in Therapy.2023; 40(12): 5432.     CrossRef
  • 18,118 View
  • 1,511 Download
  • 21 Web of Science
  • Crossref

Liver fibrosis, cirrhosis, and portal hypertension

Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clin Mol Hepatol 2022;28(1):31-46.
Published online August 2, 2021
DOI: https://doi.org/10.3350/cmh.2021.0148
Acute kidney injury (AKI) is common in advanced cirrhosis. Prerenal azotemia, hepatorenal syndrome, and acute tubular necrosis are the main causes of AKI in patients with cirrhosis. Evaluation of renal function and differentiation between functional and structural kidney injury are important issues in the management of cirrhosis. However, AKI in cirrhosis exists as a complex clinical spectrum rather than concrete clinical entity. Based on current evidence, changes in serum creatinine (Cr) levels remain the most appropriate standard for defining AKI in cirrhosis. However, serum Cr has a limited role in assessing renal function in this population. This review examines previous studies that investigated the ability of recent biomarkers for AKI in cirrhosis from the perspective of earlier and accurate diagnosis, classification of AKI phenotype, and prediction of clinical outcomes. Serum cystatin C and urine neutrophil gelatinase-associated lipocalin have been extensively studied in cirrhosis, and have facilitated improved diagnosis and prognosis prediction in patients with AKI. In addition, urine N-acetyl-β-D-glucosaminidase, interleukin 18, and kidney injury molecule 1 are other promising biomarkers for advanced cirrhosis. However, the clinical significance of these markers remains unclear because there are no cut-off values defining the normal range and differentiating phenotypes of AKI. In addition, AKI has been defined in terms of serum Cr, and renal biopsy—the gold standard—has not been carried out in most studies. Further discovery of innovate biomarkers and incorporation of various markers could improve the diagnosis and prognosis prediction of AKI, and will translate into meaningful improvements in patient outcomes.

Citations

Citations to this article as recorded by  Crossref logo
  • The Value of T1 and T2 Mapping in Diagnosing Chronic Liver Disease–related Kidney Injury and Monitoring the Outcome of Stem Cell Therapy: An Animal Experimental Study
    Jiaming Qin, Hongtao Yuan, Chao Wang, Yue Wang, Dan Tong, Zhandong Hu, Chen Zhang, Wen Shen, Shuangshuang Xie
    Magnetic Resonance in Medical Sciences.2026;[Epub]     CrossRef
  • Evaluation of Acute Kidney Injury (AKI) Biomarkers FABP1, NGAL, Cystatin C and IL-18 in an Indian Cohort of Hospitalized Acute-on-chronic Liver Failure (ACLF) Patients
    Rohini Saha, Samriddhi Sharma, Antara Mondal, Hem C. Sati, Maroof A. Khan, Sandeep Mahajan, Sudip Datta, Shalimar, Pragyan Acharya
    Journal of Clinical and Experimental Hepatology.2025; 15(3): 102491.     CrossRef
  • The efficacy of novel biomarkers for the early detection and management of acute kidney injury: A systematic review
    Mohammed Yousef Almulhim, Gianpaolo Reboldi
    PLOS ONE.2025; 20(1): e0311755.     CrossRef
  • Neutrophil gelatinase–associated lipocalin for predicting acute kidney injury in orthotopic liver transplantation: a systematic review and meta-analysis
    Fangran Yan, Zenghua Zhou, Xueke Du, Sheng He, Linghui Pan
    European Journal of Gastroenterology & Hepatology.2025; 37(6): 683.     CrossRef
  • Understanding acute kidney injury in cirrhosis: Current perspective
    Sayan Malakar, Sumit Rungta, Arghya Samanta, Umair Shamsul Hoda, Piyush Mishra, Gaurav Pande, Akash Roy, Suprabhat Giri, Praveer Rai, Samir Mohindra, Uday C Ghoshal
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Protective effects of Katsuwonus pelamis hydrolysates against renal injury: Val-Lys as a potent renoprotective peptide
    Ying Cheng, Mingjie Zhou, Zishan Hong, Lin Zheng, Mouming Zhao
    Food & Function.2025; 16(13): 5616.     CrossRef
  • Acute Kidney Injury in Patients with Liver Cirrhosis: From Past to Present Definition and Diagnosis
    Andreea Lungu, Georgiana-Elena Sarbu, Alexandru Sebastian Cotlet, Ilie-Andreas Savin, Ioana-Roxana Damian, Simona Juncu, Cristina Muzica, Irina Girleanu, Ana-Maria Sîngeap, Carol Stanciu, Anca Trifan, Camelia Cojocariu
    Life.2025; 15(8): 1249.     CrossRef
  • The Value of Diffusion Kurtosis Imaging to Assess Liver and Kidney Recovery after Mesenchymal Stem Cell Intervention in CCl4-Induced Cirrhotic Rats
    Jiaming Qin, Shuangshuang Xie, Yongquan Yu, Cheng Zhang, Yumeng Zhao, Dan Tong, Zhandong Hu, Jinxia Zhu, Wen Shen
    American Journal of Nephrology.2025; 56(4): 475.     CrossRef
  • CIRROSE HEPÁTICA EM ESTÁGIO AVANÇADO E O PAPEL DO TRANSPLANTE DE FÍGADO: DESAFIOS ATUAIS E PERSPECTIVAS FUTURAS NO MANEJO DE PACIENTES COM DOENÇA HEPÁTICA TERMINAL
    Gabriel Duarte do Nascimento, Gustavo Ribeiro Mesquita, Gilson Augusto Nunes Martins Pombeiro
    Revista Contemporânea.2025; 5(8): e8869.     CrossRef
  • Nationwide analysis of renal outcomes in chronic hepatitis B patients treated with Tenofovir Alafenamide vs. Entecavir
    Hyuk Kim, Jae Young Kim, Hye-Jin Yoo, Log Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Association between the C-reactive protein–triglyceride–glucose index (CTI) and the risk of acute kidney injury in critically ill patients with cirrhosis
    Lu-Huai Feng, Tianbao Liao, Tingting Su, Xuefei Zhou, Yang Lu, Lina Huang, Zhenhua Yang
    BMC Nephrology.2025;[Epub]     CrossRef
  • Delhi Model: A New Tool for Predicting Response to Terlipressin in Hepatorenal Syndrome—Acute Kidney Injury
    Jatin Agrawal, Ashish Kumar, Praveen Sharma, Naresh Bansal, Vikas Singla, Samarth Sharma, Anil Arora
    Journal of Clinical and Experimental Hepatology.2024; 14(1): 101266.     CrossRef
  • Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
    Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
    The Journal of Infectious Diseases.2024; 229(1): 108.     CrossRef
  • VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis
    Shohei Asada, Tadashi Namisaki, Kosuke Kaji, Hiroaki Takaya, Takahiro Kubo, Takemi Akahane, Hideto Kawaratani, Norihisa Nishimura, Soichi Takeda, Hiroyuki Masuda, Akihiko Shibamoto, Takashi Inoue, Satoshi Iwai, Fumimasa Tomooka, Yuki Tsuji, Yukihisa Fujin
    Digestive Diseases and Sciences.2024; 69(3): 851.     CrossRef
  • Evaluation of Kidney Injury Using Arterial Spin Labeling and Blood Oxygen Level‐Dependent MRI: An Experimental Study in Rats With Carbon Tetrachloride‐Induced Liver Cirrhosis
    Jiaming Qin, Shuangshuang Xie, Yongquan Yu, Jiaqi Yang, Yumeng Zhao, Caixin Qiu, Xiaotian Li, Cheng Zhang, Zhandong Hu, Dan Tong, Jinxia Zhu, Bernd Kuehn, Wen Shen
    Journal of Magnetic Resonance Imaging.2024;[Epub]     CrossRef
  • Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
    M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi, S.L. Chub, Yu.V. Nerushchenko
    GASTROENTEROLOGY.2024; 58(2): 151.     CrossRef
  • Development and validation of a web-based nomogram for acute kidney injury in acute non-variceal upper gastrointestinal bleeding patients
    Chaolian Wei, Honghua Cao, Lina Huang, Lu-Huai Feng
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?
    Hubert Zywno, Wojciech Figiel, Michal Grat, Slawomir Nazarewski, Zbigniew Galazka, Jolanta Malyszko
    International Journal of Molecular Sciences.2024; 25(22): 12072.     CrossRef
  • Novel biomarkers of acute kidney injury in chronic liver disease: Where do we stand after a decade of research?
    Rohan Vijay Yewale, Balakrishnan Siddartha Ramakrishna
    Hepatology Research.2023; 53(1): 3.     CrossRef
  • Medication dosing in adult patients with reduced lean body mass and kidney injury: A focus on cystatin C
    Brian L Erstad, David E Nix
    American Journal of Health-System Pharmacy.2023; 80(12): 712.     CrossRef
  • Acute kidney injury in patients with acute-on-chronic liver failure: clinical significance and management
    Jeong-Ju Yoo, Moo Yong Park, Sang Gyune Kim
    Kidney Research and Clinical Practice.2023; 42(3): 286.     CrossRef
  • Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status
    Xiao Liu, Shaomin Gong, Yichun Ning, Yang Li, Huili Zhou, Luna He, Lin Lin, Shi Jin, Ziyan Shen, Bowen Zhu, Fang Li, Jie Li, Xiao Tan, Xiaoyan Jiao, Yiqin Shi, Xiaoqiang Ding
    BMC Nephrology.2023;[Epub]     CrossRef
  • Hepatorenal syndrome: Current concepts and future perspectives
    Chan-Young Jung, Jai Won Chang
    Clinical and Molecular Hepatology.2023; 29(4): 891.     CrossRef
  • Diagnostic value of combined detection of urine NGAL, KIM-1, and TFF3 in acute tubular necrosis associated with cirrhosis
    Yan-Qing Gong, Ying Zhao, Yan-Hui Jia, Man Li, Yong Jiang
    World Chinese Journal of Digestology.2023; 31(19): 808.     CrossRef
  • Influence of fluid balance on postoperative outcomes after hepatic resection in patients with left ventricular diastolic dysfunction
    Jungho Shin, Suk-Won Suh
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis
    Pooja Basthi Mohan, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Balaji Musunuri, Ravindra Prabhu Attur, Ganesh Bhat, Shailesh, Shiran Shetty
    Clinica Chimica Acta.2021; 523: 339.     CrossRef
  • 13,110 View
  • 375 Download
  • 25 Web of Science
  • Crossref

Case Report

Viral hepatitis

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol 2016;22(2):286-291.
Published online June 25, 2016
DOI: https://doi.org/10.3350/cmh.2015.0066
Tenofovir disoproxil fumarate (TDF) is effective against chronic hepatitis B (CHB) infection and its use is increasing rapidly worldwide. However, it has been established that TDF is associated with renal toxicity in human immunodeficiency virus-infected patients, while severe or symptomatic TDF-associated nephrotoxicity has rarely been reported in patients with CHB. Here we present two patients with TDF-associated nephrotoxicity who were being treated for CHB infection. The first patient was found to have clinical manifestations of proximal renal tubular dysfunction and histopathologic evidence of acute tubular necrosis at 5 months after starting TDF treatment. The second patient developed acute kidney injury at 17 days after commencing TDF, and he was found to have membranoproliferative glomerulonephritis with acute tubular injury. The renal function improved in both patients after discontinuing TDF. We discuss the risk factors for TDF-associated renal toxicity and present recommendations for monitoring renal function during TDF therapy.

Citations

Citations to this article as recorded by  Crossref logo
  • Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection—General and Special Populations
    Lung‐Yi Mak, Tsung‐Hui Hu, Desmond Y. H. Yap
    Alimentary Pharmacology & Therapeutics.2026; 63(7): 945.     CrossRef
  • Urinary Levels of Neutrophil Gelatinase-associated Lipocalin and Cystatin C in Patients with Hepatitis B on Tenofovir Treatment
    Shivani Rani, Himanshu Dandu, Ambuj Yadav, Mahak Lamba, Amit Goel, Wahid Ali, Virendra Atam, Sumit Rungta, Medhavi Gautam, Atin Singhai
    Journal of The Association of Physicians of India.2025; 73(2): 13.     CrossRef
  • Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
    David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B
    Young Youn Cho, Young Chang, Joon Yeul Nam, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
    Gut and Liver.2020; 14(2): 225.     CrossRef
  • Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma
    Mi Young Jeon, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Seung Up Kim
    Journal of Viral Hepatitis.2020; 27(9): 932.     CrossRef
  • Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment—still an open issue
    Sung Won Lee, Seung Up Kim
    Alimentary Pharmacology & Therapeutics.2020; 52(5): 889.     CrossRef
  • Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients
    Sang Jin Kim, Jinsoo Rhu, Seo Hee Lee, Jong Man Kim, Gyu-Seong Choi, Kyunga Kim, Jae-Won Joh
    Annals of Surgical Treatment and Research.2020; 99(3): 180.     CrossRef
  • A severe case of tenofovir-associated acute kidney injury requiring hemodialysis in a patient with chronic hepatitis B
    A Young Cho, Ju Hwan Oh, Hee-Chan Moon, Gum Mo Jung, Young Suk Lee, Yeong Jin Choi, In O Sun, Kwang Young Lee
    Kidney Research and Clinical Practice.2020; 39(3): 373.     CrossRef
  • Renal Dysfunction and Tubulopathy Induced by High-Dose Tenofovir Disoproxil Fumarate in C57BL/6 Mice
    Eungyeong Jang, Jong Kil Lee, Kyung-Soo Inn, Eun Kyoung Chung, Kyung-Tae Lee, Jang-Hoon Lee
    Healthcare.2020; 8(4): 417.     CrossRef
  • Application of High-Performance Liquid Chromatography for Simultaneous Determination of Tenofovir and Creatinine in Human Urine and Plasma Samples
    Patrycja Olejarz, Grażyna Chwatko, Paweł Kubalczyk, Krystian Purgat, Rafał Głowacki, Kamila Borowczyk
    Pharmaceuticals.2020; 13(11): 367.     CrossRef
  • Tenofovir-Associated Acute Kidney Disease: Is it Different in HIV- and HBV-Infected Patients?
    Fatemeh Ghasemi, Mohammadreza Salehi, Niloofar Khoshnam Rad, Hossein Khalili
    American Journal of Therapeutics.2019; 26(5): e639.     CrossRef
  • Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
    Young Youn Cho, Young Hwan Choi, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon
    Journal of Liver Cancer.2019; 19(2): 128.     CrossRef
  • Effect of tenofovir on renal function in patients with chronic hepatitis B
    Woo Jin Jung, Jae Young Jang, Won Young Park, Soung Won Jeong, Hee Jeong Lee, Sang Joon Park, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Baigal Baymbajav
    Medicine.2018; 97(7): e9756.     CrossRef
  • Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients
    H. J. Tsai, Y. W. Chuang, S. W. Lee, C. Y. Wu, H. Z. Yeh, T. Y. Lee
    Alimentary Pharmacology & Therapeutics.2018; 47(12): 1673.     CrossRef
  • Tenofovir disoproxil fumarate

    Reactions Weekly.2016; 1617(1): 214.     CrossRef
  • 16,132 View
  • 179 Download
  • 12 Web of Science
  • Crossref

Original Article

Liver fibrosis, cirrhosis, and portal hypertension

Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal
Yun Jung Choi, Jeong Han Kim, Ja Kyung Koo, Cho I Lee, Ji Young Lee, Jae Hoon Yang, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clin Mol Hepatol 2014;20(2):185-191.
Published online June 30, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.2.185
Background/Aims

A revised classification system for renal dysfunction in patients with cirrhosis was proposed by the Acute Dialysis Quality Initiative and the International Ascites Club Working Group in 2011. The aim of this study was to determine the prevalence of renal dysfunction according to the criteria in this proposal.

Methods

The medical records of cirrhotic patients who were admitted to Konkuk University Hospital between 2006 and 2010 were reviewed retrospectively. The data obtained at first admission were collected. Acute kidney injury (AKI) and chronic kidney disease (CKD) were defined using the proposed diagnostic criteria of kidney dysfunction in cirrhosis.

Results

Six hundred and forty-three patients were admitted, of whom 190 (29.5%), 273 (42.5%), and 180 (28.0%) were Child-Pugh class A, B, and C, respectively. Eighty-three patients (12.9%) were diagnosed with AKI, the most common cause for which was dehydration (30 patients). Three patients had hepatorenal syndrome type 1 and 26 patients had prerenal-type AKI caused by volume deficiency after variceal bleeding. In addition, 22 patients (3.4%) were diagnosed with CKD, 1 patient with hepatorenal syndrome type 2, and 3 patients (0.5%) with AKI on CKD.

Conclusions

Both AKI and CKD are common among hospitalized cirrhotic patients, and often occur simultaneously (16.8%). The most common type of renal dysfunction was AKI (12.9%). Diagnosis of type 2 hepatorenal syndrome remains difficult. A prospective cohort study is warranted to evaluate the clinical course in cirrhotic patients with renal dysfunction.

Citations

Citations to this article as recorded by  Crossref logo
  • Korean Society of Nephrology 2025 evidence-based clinical practice guideline for continuous kidney replacement therapy
    Jeonghwan Lee, Donghyuk Kang, Jin Hyuk Paek, Jangwook Lee, Jung Nam An, Junseok Jeon, Kyungho Lee, Hye Ryoun Jang, Jong Hyun Jhee, Hyo Jin Kim, Harin Rhee, Sung Yoon Lim, Jihyun Yang, Seong Geun Kim, Seung Seok Han, Shin Young Ahn, Sunghoon Park, Hyun Kyu
    Kidney Research and Clinical Practice.2026; 45(Suppl 1): S1.     CrossRef
  • Korean Society of Nephrology 2025 Evidence-Based Clinical Practice Guideline for Continuous Kidney Replacement Therapy
    Jeonghwan Lee, Donghyuk Kang, Jin Hyuk Paek, Jangwook Lee, Jung Nam An, Junseok Jeon, Kyungho Lee, Hye Ryoun Jang, Jong Hyun Jhee, Hyo Jin Kim, Harin Rhee, Sung Yoon Lim, Jihyun Yang, Seong Geun Kim, Seung Seok Han, Shin Young Ahn, Sunghoon Park, Hyun Kyu
    Electrolytes & Blood Pressure.2026; 24(1): 6.     CrossRef
  • Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta‐Analysis of Over 5 Million Patients Across Different Clinical Settings
    Vasileios Lekakis, Florence Wong, Aikaterini Gkoufa, George V. Papatheodoridis, Evangelos Cholongitas
    Alimentary Pharmacology & Therapeutics.2025; 61(3): 420.     CrossRef
  • A novel risk-predicted nomogram for acute kidney injury progression in decompensated cirrhosis: a double-center study in Vietnam
    Nghia N. Nguyen, Bao T. Nguyen, Thuy D. T. Nguyen, Tam T. T. Tran, Tan N. H. Mai, Huyen N. T. Le, Hoang N. Dang, Vy B. N. Nguyen, Nhi Y. T. Ngo, Cuong T. Vo
    International Urology and Nephrology.2025; 57(7): 2279.     CrossRef
  • Gynura procumbens leaf extract-loaded self-microemulsifying drug delivery system offers enhanced protective effects in the hepatorenal organs of the experimental rats
    Manik Chandra Shill, Md. Faisal Bin Jalal, Madhabi Lata Shuma, Patricia Prova Mollick, Md. Abdul Muhit, Shimul Halder, Miquel Vall-llosera Camps
    PLOS ONE.2025; 20(2): e0304435.     CrossRef
  • Biopharmaceutical characterization of Ajwain (Carum copticum) seed extract-loaded self-microemulsifying drug delivery system for enhanced hepatoprotective and nephroprotective activity
    Shimul Halder, Fatema-Tuz-Zohora, Tania Ahmed Chowdhury, Leon Bhowmik, Madhabi Lata Shuma, Harinarayan Das, Sulobh Sarkar, Md. Abdul Muhit, Manik Chandra Shill
    Scientific Reports.2025;[Epub]     CrossRef
  • Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
    Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
    The Journal of Infectious Diseases.2024; 229(1): 108.     CrossRef
  • Study of prevalence, risk factors for acute kidney injury, and mortality in liver cirrhosis patients
    Pooja Basthi Mohan, Shankar Prasad Nagaraju, Balaji Musunuri, Siddheesh Rajpurohit, Ganesh Bhat, Shiran Shetty
    Irish Journal of Medical Science (1971 -).2024; 193(4): 1817.     CrossRef
  • Incidence and risk factors of acute kidney injury in cirrhosis: a systematic review and meta-analysis of 5,202,232 outpatients, inpatients, and ICU-admitted patients
    Vasileios Lekakis, Aikaterini Gkoufa, John Vlachogiannakos, George V. Papatheodoridis, Evangelos Cholongitas
    Expert Review of Gastroenterology & Hepatology.2024; 18(7): 377.     CrossRef
  • Acute kidney injury development and impact on clinical and economic outcomes in patients with cirrhosis: an observational cohort study over a 10-year period
    Osama Y. Alshogran, Shoroq M. Altawalbeh, Eman M. Almestarihi
    European Journal of Gastroenterology & Hepatology.2023; 35(4): 497.     CrossRef
  • Addition of Kidney Dysfunction Type to MELD-Na for the Prediction of Survival in Cirrhotic Patients Awaiting Liver Transplantation in Comparison with MELD 3.0 with Albumin
    Kyeong-Min Yeom, Jong-In Chang, Jeong-Ju Yoo, Ji Eun Moon, Dong Hyun Sinn, Young Seok Kim, Sang Gyune Kim
    Diagnostics.2023; 14(1): 39.     CrossRef
  • Acute Kidney Injury in Patients with Liver Cirrhosis: Prevalence, Predictors, and In‐Hospital Mortality at a District Hospital in Ghana
    Amoako Duah, Francisca Duah, Daniel Ampofo-Boobi, Bright Peprah Addo, Foster Osei-Poku, Adwoa Agyei-Nkansah, Maria Irene Bellini
    BioMed Research International.2022;[Epub]     CrossRef
  • Impact of acute kidney injury on the risk of mortality in patients with cirrhosis: a systematic review and meta-analysis
    Yunfeng Ning, Xiaoyue Zou, Jing Xu, Xiao Wang, Min Ding, Hulin Lu
    Renal Failure.2022; 44(1): 1934.     CrossRef
  • Keeping Patients with End-Stage Liver Disease Alive While Awaiting Transplant
    Andres F. Carrion, Paul Martin
    Clinics in Liver Disease.2021; 25(1): 103.     CrossRef
  • Chronic renal dysfunction in cirrhosis: A new frontier in hepatology
    Ramesh Kumar, Rajeev Nayan Priyadarshi, Utpal Anand
    World Journal of Gastroenterology.2021; 27(11): 990.     CrossRef
  • Predictors of Development of Hepatorenal Syndrome in Hospitalized Cirrhotic Patients with Acute Kidney Injury
    Roula Sasso, Ahmad Abou Yassine, Liliane Deeb
    Journal of Clinical Medicine.2021; 10(23): 5621.     CrossRef
  • Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis
    Pooja Basthi Mohan, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Balaji Musunuri, Ravindra Prabhu Attur, Ganesh Bhat, Shailesh, Shiran Shetty
    Clinica Chimica Acta.2021; 523: 339.     CrossRef
  • Acute kidney injury and hepatorenal syndrome in cirrhosis
    Kapil Gupta, Abhishek Bhurwal, Cindy Law, Scott Ventre, Carlos D Minacapelli, Savan Kabaria, You Li, Christopher Tait, Carolyn Catalano, Vinod K Rustgi
    World Journal of Gastroenterology.2021; 27(26): 3984.     CrossRef
  • Diagnosis and management of renal dysfunction in patients with cirrhosis
    Andres F. Carrion, Ramya Radhakrishnan, Paul Martin
    Expert Review of Gastroenterology & Hepatology.2020; 14(1): 1.     CrossRef
  • Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI?
    Zehao Tan, Wey Chyi Teoh, Kang Min Wong, Gervais Khin-Lin Wansaicheong, Kumaresan Sandrasegaran
    Clinical Imaging.2020; 62: 63.     CrossRef
  • Evaluation of Renal Disease in Patients With Cirrhosis
    Erik L. Lum, Piyavadee Homkrailas, Suphamai Bunnapradist
    Journal of Clinical Gastroenterology.2020; 54(4): 314.     CrossRef
  • Incidence, Mortality and Predictors of Acute Kidney Injury in Patients with Cirrhosis: A Systematic Review and Meta-analysis
    Raseen Tariq, Yousaf Hadi, Khusdeep Chahal, Sivani Reddy, Habeeb Salameh, Ashwani K. Singal
    Journal of Clinical and Translational Hepatology.2020; 8(2): 135.     CrossRef
  • Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma
    Paulo Henrique Lima, Boyan Fan, Joshua Bérubé, Milena Cerny, Damien Olivié, Jeanne-Marie Giard, Catherine Beauchemin, An Tang
    American Journal of Roentgenology.2019; 213(1): 17.     CrossRef
  • Impact of Chronic Kidney Disease on Outcomes in Cirrhosis
    Florence Wong, K. Rajender Reddy, Jacqueline G. O’Leary, Puneeta Tandon, Scott W. Biggins, Guadalupe Garcia‐Tsao, Benedict J. Maliakkal, Jennifer C. Lai, Michael B. Fallon, Hugo E. Vargas, Ram Subramanian, Paul J. Thuluvath, Patrick S. Kamath, Leroy Thack
    Liver Transplantation.2019; 25(6): 870.     CrossRef
  • Factors associated with renal dysfunction in hepatitis C-related cirrhosis and its correlation with Child-Pugh score
    Hamza Waqar Bhatti, Umama Tahir, Noman Ahmed Chaudhary, Sania Bhatti, Muhammad Hafeez, Zuhair Ali Rizvi
    BMJ Open Gastroenterology.2019; 6(1): e000286.     CrossRef
  • Spectrum of hepatitis B and renal involvement
    Apurva S. Shah, Deepak N. Amarapurkar
    Liver International.2018; 38(1): 23.     CrossRef
  • Renal dysfunction in liver cirrhosis and its correlation with Child-Pugh score and MELD score
    G A Siregar, M Gurning
    IOP Conference Series: Earth and Environmental Science.2018; 125: 012214.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

    Clinical and Molecular Hepatology.2018; 24(3): 230.     CrossRef
  • The prevalence and association of chronic kidney disease and diabetes in liver cirrhosis using different estimated glomerular filtration rate equation
    Cheng-Yi Chen, Cheng-Jui Lin, Chih-Sheng Lin, Fang-Ju Sun, Chi-Feng Pan, Han-Hsiang Chen, Chih-Jen Wu
    Oncotarget.2018; 9(2): 2236.     CrossRef
  • Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?
    Andrew Davenport, Mohammed Faisal Sheikh, Edmund Lamb, Banwari Agarwal, Rajiv Jalan
    Kidney International.2017; 92(5): 1058.     CrossRef
  • Clinical Outcomes of Peritoneal Dialysis in End-Stage Renal Disease Patients with Liver Cirrhosis: A Propensity Score Matching Study
    Su Mi Lee, Young Ki Son, Seong Eun Kim, Won Suk An
    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis.2017; 37(3): 314.     CrossRef
  • Appréciation du débit de filtration glomérulaire et de la dysfonction rénale chez le cirrhotique
    C. Mousseaux, A. Bouguerba, S. Ayed, J. Barchasz, M. Boukari, D. Goldgran-Toledano, C. Bornstain, F. Vincent
    Réanimation.2016; 25(S3): 137.     CrossRef
  • Assessment of renal functions in patients of chronic liver disease
    H. K. Aggarwal, Deepak Jain, Suhas Singla, Promil Jain
    Renal Failure.2015; 37(9): 1457.     CrossRef
  • 13,690 View
  • 122 Download
  • 38 Web of Science
  • Crossref

Case Report

Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report
Jihyun An, Joo Ho Lee, Hyojeong Lee, Eunsil Yu, Dan Bi Lee, Ju Hyun Shim, Sunyoung Yoon, Yumi Lee, Soeun Park, Han Chu Lee
Korean J Hepatol 2012;18(1):84-88.
Published online March 22, 2012
DOI: https://doi.org/10.3350/kjhep.2012.18.1.84

Hepatitis A virus (HAV) infections occur predominantly in children, and are usually self-limiting. However, 75-95% of the infections in adults are symptomatic (mostly with jaundice), with the illness symptoms usually persisting for a few weeks. Atypical manifestations include relapsing hepatitis, prolonged cholestasis, and complications involving renal injury. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, drug-induced hypersensitivity reaction characterized by skin rash, fever, lymph-node enlargement, and internal organ involvement. We describe a 22-year-old male who presented with acute kidney injury and was diagnosed with prolonged cholestatic hepatitis A. The patient also developed DRESS syndrome due to antibiotic and/or antiviral treatment. To our knowledge, this is the first report of histopathologically confirmed DRESS syndrome due to antibiotic and/or antiviral treatment following HAV infection with cholestatic features and renal injury.

Citations

Citations to this article as recorded by  Crossref logo
  • Prolonged Cholestatic Hepatitis A With Transient Epstein-Barr Virus IgM Reactivity and Marked Hyperferritinemia in an HFE H63D Heterozygote
    Sara R Silva, Filipe Dias, Cláudia Ribeiro, Fátima Augusto, Cátia Albino
    Cureus.2026;[Epub]     CrossRef
  • Treatment of Prolonged Cholestasis with Systemic Steroid in Acute Hepatitis A: A Case Report
    Jae Hyun Yoon, Youngeun Seo, Sung Bum Cho
    Convergence Hepatology.2025; 1(1): 85.     CrossRef
  • Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan
    Tatsuo Kanda, Reina Sasaki‐Tanaka, Koji Ishii, Ryosuke Suzuki, Jun Inoue, Atsunori Tsuchiya, Shingo Nakamoto, Ryuzo Abe, Keiichi Fujiwara, Osamu Yokosuka, Tian‐Cheng Li, Satoshi Kunita, Hiroshi Yotsuyanagi, Hiroaki Okamoto
    Hepatology Research.2024; 54(1): 4.     CrossRef
  • DRESS syndrome with cholecystitis in a child: A case report and literature review
    Ferdaous Chahed, Najah Ben Fadhel, Haifa Ben Romdhane, Zohra Chadli, Habib Besbes, Naceur Boughattas, Nadia Ben Fredj, Karim Aouam
    Therapies.2022; 77(5): 622.     CrossRef
  • Characterizing DRESS syndrome recurrence: a systematic review
    Ajay N. Sharma, Samantha Shwe, Vignesh Ravi, Melanie Miller, Natasha A. Mesinkovska, Nathan W. Rojek, Scott Worswick
    Archives of Dermatological Research.2021; 314(8): 721.     CrossRef
  • Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances
    Teresa Bellón
    Drug Safety.2019; 42(8): 973.     CrossRef
  • Variation of clinical manifestations according to culprit drugs in DRESS syndrome
    Da Woon Sim, Ji Eun Yu, Jiung Jeong, Jae‐Woo Jung, Hye‐Ryun Kang, Dong Yoon Kang, Young Min Ye, Young‐Koo Jee, Sujeong Kim, Jung‐Won Park, Min Gyu Kang, Sae Hoon Kim, Hye‐Kyung Park, Min‐Suk Yang, Gyu‐Young Hur, Jun Kyu Lee, Jeong‐Hee Choi, Yong Eun Kwon,
    Pharmacoepidemiology and Drug Safety.2019; 28(6): 840.     CrossRef
  • Allopurinol-induced DRESS syndrome mimicking biliary obstruction
    Hyung Gyu Choi, Junsu Byun, Chae Ho Moon, Jong Ho Yoon, Ki Young Yang, Su Cheol Park, Chul Ju Han
    Clinical and Molecular Hepatology.2014; 20(1): 71.     CrossRef
  • Dress Syndrome Induced by Sulphasalazine
    K. Pałgan, Z. Bartuzi
    European Journal of Inflammation.2014; 12(1): 187.     CrossRef
  • Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
    S. Ständer, D. Metze, T. Luger, T. Schwarz
    Der Hautarzt.2013; 64(8): 611.     CrossRef
  • 10,540 View
  • 62 Download
  • Crossref
Original Article
Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis
Mi Yeon Chung, Dae Won Jun, Su Ah Sung
Korean J Hepatol 2010;16(3):301-307.
Published online September 30, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.3.301
Background/Aims

The present study aimed to determine the role of cystatin C as a prognostic factor for acute kidney injury and survival in cirrhotic patients.

Methods

The study investigated 53 liver cirrhosis patients. The renal function was evaluated by serum creatinine, serum and urine cystatin C, and 24-hour creatinine clearance on admission. Acute kidney injury was defined as a serum creatinine level exceeding the normal range (>1.2 mg/dl) and an increase of at least 50% from the baseline value. Multivariate analysis, receiver operating characteristic curve, and survival analysis were used to investigate prognostic factors for acute kidney injury and survival.

Results

Nine of the 53 cirrhotic patients (17.0%) developed acute kidney injury within 3 months. Both serum creatinine and cystatin C were predictive factors for acute kidney injury in univariate analysis, with a diagnostic accuracy of 0.735 (95% confidence interval (CI), 0.525-0.945; p=0.028) for serum cystatin C and 0.698 (95% CI, 0.495-0.901, p=0.063) for creatinine. In multivariate analysis, only serum cystatin C was an independent risk factor for acute kidney injury. The sensitivity and specificity of a serum cystatin C level of >1.23 mg/L to acute kidney injury were 66% and 86%, respectively. Serum cystatin C was positively correlated with the Model for End-Stage Liver Disease (MELD) and MELD-Na scores (r=0.346 and p=0.011, and r=0.427 and p=0.001, respectively). Comparison of the survival rates over the observation period revealed that a serum cystatin C level of >1.23 mg/L was a useful marker for short-term mortality (p<0.001).

Conclusions

The accuracy in predicting acute kidney injury and short-term mortality was higher for a serum cystatin C level of >1.23 mg/L than for the serum creatinine concentration in patients with cirrhosis.

Citations

Citations to this article as recorded by  Crossref logo
  • Nephroprotective potential of robinin to counteract aldicarb induced renal dysfunction via modulating TLR4/MyD88, HMGB1/RAGE, NF-κB pathway: A biochemical and pharmacodynamic approach
    Ning Li, Fuad M. Alzahrani, Mahmoud El Safadi, Sunbal Attaullah, Khalid J. Alzahrani, Faez Falah Alshehri, Arifa Mehreen, Tawaf Ali Shah
    Food and Chemical Toxicology.2025; 197: 115298.     CrossRef
  • Understanding acute kidney injury in cirrhosis: Current perspective
    Sayan Malakar, Sumit Rungta, Arghya Samanta, Umair Shamsul Hoda, Piyush Mishra, Gaurav Pande, Akash Roy, Suprabhat Giri, Praveer Rai, Samir Mohindra, Uday C Ghoshal
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis
    Adrià Juanola, Ann Thu Ma, Koos de Wit, Kohilan Gananandan, Olivier Roux, Giacomo Zaccherini, César Jiménez, Marta Tonon, Cristina Solé, Clara Villaseca, Frank E Uschner, Isabel Graupera, Elisa Pose, Maria José Moreta, Daniela Campion, Ulrich Beuers, Raje
    Gut.2024; 73(1): 156.     CrossRef
  • Predictive value of lipocalin 2 and cystatin C for acute kidney injury in patients with cirrhosis
    Xue-Qing Ma, Si-Si Yang, Huan-Qiu Wang, Jie Wu, Cheng-Bo Yu
    Hepatobiliary & Pancreatic Diseases International.2023; 22(1): 99.     CrossRef
  • Serum Cystatin C within 24 hours after admission: a potential predictor for acute kidney injury in Chinese patients with community acquired pneumonia
    Dawei Chen, Linglin Jiang, Yan Tan, Jing Zhao, Wenjuan Huang, Binbin Pan, Xin Wan
    Renal Failure.2023;[Epub]     CrossRef
  • Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment
    Krzysztof Badura, Weronika Frąk, Joanna Hajdys, Gabriela Majchrowicz, Ewelina Młynarska, Jacek Rysz, Beata Franczyk
    International Journal of Molecular Sciences.2023; 24(24): 17469.     CrossRef
  • Role of Serum Cystatin C as a Diagnostic Tool for Renal Function in Cirrhotic Patients
    Fathia Elsayed Asal, Mohamed Yousef, Hend Atteya Abdelkhalek Abdraboh, Sherief Abd-Elsalam, Ahmed Abdelaziz Abdelaziz Shama, Mohamed Elbahnasawy, Mohammed H Elnaggar, Hesham Ahmed Alsrogy, Heba Elashry
    The Open Biomarkers Journal.2022;[Epub]     CrossRef
  • Cystatin C in Patients with Acute Kidney Injury after Liver Transplantation
    晓蒙 杨
    Advances in Clinical Medicine.2021; 11(05): 2422.     CrossRef
  • Serum cystatin C as a predictor of 90‐day mortality among patients admitted with complications of cirrhosis
    Anuchit Suksamai, Amnart Chaiprasert, Sakkarin Chirapongsathorn
    JGH Open.2021; 5(5): 607.     CrossRef
  • Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis
    Priti Vijay, Bikrant Bihari Lal, Vikrant Sood, Rajeev Khanna, Seema Alam
    European Journal of Pediatrics.2021; 180(11): 3287.     CrossRef
  • Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure
    Praveen Jha, Ashish Kumar Jha, Vishwa Mohan Dayal, Sanjeev Kumar Jha, Amarendra Kumar
    Indian Journal of Gastroenterology.2021; 40(6): 563.     CrossRef
  • Acute kidney injury in children with chronic liver disease
    Akash Deep, Romit Saxena, Bipin Jose
    Pediatric Nephrology.2019; 34(1): 45.     CrossRef
  • Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study
    Rakhi Maiwall, Awinash Kumar, Ankit Bhardwaj, Guresh Kumar, Ajeet S. Bhadoria, Shiv K. Sarin
    Liver International.2018; 38(4): 654.     CrossRef
  • Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis
    Lei Lei, Liang Ping Li, Zhen Zeng, Jing Xi Mu, Xue Yang, Chao Zhou, Zhi Lan Wang, Hu Zhang
    Scientific Reports.2018;[Epub]     CrossRef
  • Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?
    Ümmügülsüm Gaygısız, Müge Aydoğdu, Melike Badoğlu, Nazlıhan Boyacı, Zuhal Güllü, Gül Gürsel
    Scandinavian Journal of Clinical and Laboratory Investigation.2016; 76(2): 143.     CrossRef
  • Prognostic value of serum cystatin C levels in cirrhotic patients with normal serum creatinine
    Bilyana Teneva, Emiliya Karaslavova
    Open Medicine.2014; 9(5): 625.     CrossRef
  • Impact of Birth Cohort Screening for Hepatitis C
    Sumeet K. Asrani, Gary L. Davis
    Current Gastroenterology Reports.2014;[Epub]     CrossRef
  • Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury
    Justin M. Belcher, Arun J. Sanyal, Guadalupe Garcia-Tsao, Naheed Ansari, Steven G. Coca, Michael G. Shlipak, Chirag R. Parikh
    International Journal of Nephrology.2014; 2014: 1.     CrossRef
  • The impacts of thyroid function on the diagnostic accuracy of Cystatin C to detect acute kidney injury in ICU patients: a prospective, observational study
    Feilong Wang, Wenzhi Pan, Hairong Wang, Yu Zhou, Shuyun Wang, Shuming Pan
    Critical Care.2014;[Epub]     CrossRef
  • Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels
    Dong Jin Kim, Hyun Seok Kang, Hyuk Soon Choi, Hye Jin Cho, Eun Sun Kim, Bora Keum, Hyonggin An, Ji Hoon Kim, Yeon Seok Seo, Yong Sik Kim, Hyung Joon Yim, Yoon Tae Jeen, Hong Sik Lee, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu
    The Korean Journal of Hepatology.2011; 17(2): 130.     CrossRef
  • Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysis
    Zhongheng Zhang, Baolong Lu, Xiaoyan Sheng, Ni Jin
    American Journal of Kidney Diseases.2011; 58(3): 356.     CrossRef
  • 13,073 View
  • 81 Download
  • Crossref